Blair Eve M, Nelson Karin B
Telethon Kids Institute, University of Western Australia, West Perth, Western Australia.
Department of Neurology, Children's National Medical Center, Washington, DC; Scientist Emeritus, National Institute of Neurological Disease and Stroke, Bethesda, MD.
Am J Obstet Gynecol. 2015 Apr;212(4):520.e1-7. doi: 10.1016/j.ajog.2014.10.1103. Epub 2014 Oct 30.
The objective of the study was to improve the understanding of etiological paths to cerebral palsy (CP) that include fetal growth restriction by examining factors associated with growth restriction that modify CP risk.
In a total population of singletons born at or after 35 weeks, there were 493 children with CP and 508 matched controls for whom appropriateness of fetal growth could be estimated. Fetal growth was considered markedly restricted if birthweight was more than 2 SD below optimal for gender, gestation, maternal height, and parity. We examined maternal blood pressure in pregnancy, smoking, birth asphyxia, and major birth defects recognized by age 6 years as potential modifiers of CP risk in growth-restricted births.
More than 80% of term and late preterm markedly growth-restricted singletons were born following a normotensive pregnancy and were at statistically significantly increased risk of CP (odds ratio, 4.81; 95% confidence interval, 2.7-8.5), whereas growth-restricted births following a hypertensive pregnancy were not. Neither a clinical diagnosis of birth asphyxia nor potentially asphyxiating birth events occurred more frequently among growth-restricted than among appropriately grown infants with CP. Major birth defects, particularly cerebral defects, occurred in an increasing proportion of CP with increasing growth deficit. The factor most predictive of CP in growth-restricted singletons was a major birth defect, present in 53% of markedly growth-restricted neonates with later CP. Defects observed in CP were similar whether growth restricted or not, except for an excess of isolated congenital microcephaly in those born growth restricted. The highest observed CP risk was in infants with both growth restriction and a major birth defect (8.9% of total CP in this gestational age group, 0.4% of controls: odds ratio, 30.9; 95% confidence interval, 7.0-136).
The risk of CP was increased in antenatally growth-restricted singletons born at or near term to normotensive mothers. In growth-restricted singletons, a major birth defect was the dominant predictor, associated with a 30-fold increase in odds of CP. Identification of birth defects in the growth-restricted fetus or neonate may provide significant prognostic information.
本研究的目的是通过检查与生长受限相关的因素(这些因素会改变脑瘫(CP)风险)来加深对包括胎儿生长受限在内的脑瘫病因路径的理解。
在35周及以后出生的单胎总人群中,有493例脑瘫患儿和508例匹配的对照,可评估其胎儿生长是否合适。如果出生体重比根据性别、孕周、母亲身高和产次计算出的最佳体重低2个标准差以上,则认为胎儿生长明显受限。我们检查了孕期母亲血压、吸烟情况、出生窒息以及6岁时确诊的主要出生缺陷,将其作为生长受限出生儿中脑瘫风险的潜在调节因素。
超过80%的足月儿和晚期早产儿中明显生长受限的单胎是在母亲血压正常的孕期出生的,其患脑瘫的风险在统计学上显著增加(比值比,4.81;95%置信区间,2.7 - 8.5),而母亲高血压孕期出生的生长受限儿则不然。生长受限儿中临床诊断为出生窒息或潜在窒息性出生事件的发生频率并不高于患有脑瘫的正常生长儿。随着生长缺陷程度增加,脑瘫患儿中主要出生缺陷,尤其是脑部缺陷的比例也在增加。生长受限单胎中最能预测脑瘫的因素是主要出生缺陷,在后期患脑瘫的明显生长受限新生儿中,53%存在主要出生缺陷。无论是否生长受限,脑瘫患儿中观察到的缺陷相似,但生长受限儿中孤立性先天性小头畸形过多。观察到的患脑瘫风险最高的是同时存在生长受限和主要出生缺陷的婴儿(该孕周组中脑瘫患儿总数的8.9%,对照组的0.4%:比值比,30.9;95%置信区间,7.0 - 136)。
足月或接近足月出生、母亲血压正常的产前生长受限单胎患脑瘫的风险增加。在生长受限单胎中,主要出生缺陷是主要预测因素,与患脑瘫几率增加30倍相关。识别生长受限胎儿或新生儿的出生缺陷可能提供重要的预后信息。